{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:25:10Z","timestamp":1791296710772,"version":"4.1.0"},"reference-count":192,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.actatropica.2015.12.017","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T18:30:56Z","timestamp":1451500256000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":215,"special_numbering":"C","title":["Current drug therapy and pharmaceutical challenges for Chagas disease"],"prefix":"10.1016","volume":"156","author":[{"given":"Jos\u00e9","family":"Bermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2302-5484","authenticated-orcid":false,"given":"Carolina","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2128-4711","authenticated-orcid":false,"given":"Anal\u00eda","family":"Simonazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Pablo Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2015.12.017_bib0005","unstructured":"Organization WH. Chagas disease (American trypanosomiasis) 2015. Updated March 2015. Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs340\/en\/."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0010","unstructured":"AGB. Support for Neglected Tropical Diseases 2015 [cited 2015 November 18]. Available from: http:\/\/www.bayer.com\/en\/chagas-and-african-sleeping-sickness.aspx."},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0015","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1248\/bpb.25.1485","article-title":"Ursolic acid as a trypanocidal constituent in rosemary","volume":"25","author":"Abe","year":"2002","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/glycob\/cwh079","article-title":"Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo","volume":"14","author":"Agust\u00ed","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0025","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/1756-0500-5-352","article-title":"Highly diluted medication reduces parasitemia and improves experimental infection evolution by Trypanosoma cruzi","volume":"5","author":"Aleixo","year":"2012","journal-title":"BMC Res. Notes"},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0030","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1371\/journal.pntd.0002304","article-title":"Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004\u20132009","volume":"7","author":"Alonso-Vega","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.trstmh.2012.07.010","article-title":"Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease","volume":"106","author":"Alvarez","year":"2012","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.actatropica.2015.12.017_bib0040","first-page":"721","article-title":"Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types","volume":"63","author":"Andrade","year":"1985","journal-title":"Bull. World Health Org."},{"issue":"January (1)","key":"10.1016\/j.actatropica.2015.12.017_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/1087057114555846","article-title":"High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human african trypanosomiasis, leishmaniasis, and chagas disease","volume":"20","author":"Annang","year":"2015","journal-title":"J. Biomol. Screen."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.175.1.169","article-title":"Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection","volume":"175","author":"Anon","year":"1992","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.1998.59.133","article-title":"Treatment of chronic Chagas\u2019 disease with itraconazole and allopurinol","volume":"59","author":"Apt","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1179\/000349803125002751","article-title":"Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up","volume":"97","author":"Apt","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0065","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/jac\/dkt135","article-title":"Treatment of Chagas\u2019 disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up","volume":"68","author":"Apt","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0070","doi-asserted-by":"crossref","first-page":"e0128707","DOI":"10.1371\/journal.pone.0128707","article-title":"Benznidazole\/itraconazole combination treatment enhances anti-Trypanosoma cruzi activity in experimental chagas disease","volume":"10","author":"Ass\u00edria Fontes Martins","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0075","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1073\/pnas.0307312101","article-title":"A 9000-year record of Chagas\u2019 disease","volume":"101","author":"Aufderheide","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1590\/S0100-879X2007000100005","article-title":"Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs","volume":"40","author":"Barbosa","year":"2007","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1590\/0037-8682-0003-2014","article-title":"Ventricular arrhythmias in Chagas disease","volume":"48","author":"Barbosa","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0090","doi-asserted-by":"crossref","first-page":"e0003849","DOI":"10.1371\/journal.pntd.0003849","article-title":"Trypanosoma cruzi Infection through the oral route promotes a severe infection in mice: new disease form from an old infection?","volume":"9","author":"Barreto-de-Albuquerque","year":"2015","journal-title":"PLoS Neglect. Trop. Dis."},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0095","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.poly.2010.04.023","article-title":"Manganese(II) complexes with N4-methyl-4-nitrobenzaldehyde, N4-methyl-4-nitroacetofenone, and N4-methyl-4-nitrobenzophenone thiosemicarbazone: Investigation of in vitro activity against Trypanosoma cruzi","volume":"29","author":"Batista","year":"2010","journal-title":"Polyhedron"},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0100","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.poly.2011.04.001","article-title":"Co(II), Mn(II) and Cu(II) complexes of fluoroquinolones: synthesis, spectroscopical studies and biological evaluation against Trypanosoma cruzi","volume":"30","author":"Batista","year":"2011","journal-title":"Polyhedron"},{"issue":"3","key":"10.1016\/j.actatropica.2015.12.017_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00436-008-1029-x","article-title":"Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment","volume":"103","author":"Baz\u00e1n","year":"2008","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejmech.2015.01.065","article-title":"Computer-guided drug repurposing: Identification of trypanocidal activity of clofazimine, benidipine and saquinavir","volume":"93","author":"Bellera","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0115","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1179\/136485908X311740","article-title":"Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis","volume":"102","author":"Benvenuti","year":"2008","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"November 19","key":"10.1016\/j.actatropica.2015.12.017_bib0120","first-page":"1882","article-title":"Chagas\u2019 disease","volume":"373","author":"Bern","year":"2015","journal-title":"New Engl. J. Med."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0125","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0130","doi-asserted-by":"crossref","unstructured":"Borges AR, de Albuquerque Aires JR, Higino TMM, de Medeiros MdGF, Cit\u00f3 AMdGL, Lopes JAD, et al. Trypanocidal and cytotoxic activities of essential oils from medicinal plants of Northeast of Brazil. Experimental parasitology. 2012; 132(2): 123\u2013128.","DOI":"10.1016\/j.exppara.2012.06.003"},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0135","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1128\/AAC.00800-10","article-title":"Trypanocidal activity of aziridinyl nitrobenzamide prodrugs","volume":"54","author":"Bot","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0140","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.phymed.2014.01.004","article-title":"Antiparasitic activity and effect of casearins isolated from Casearia sylvestris on Leishmania and Trypanosoma cruzi plasma membrane","volume":"21","author":"Bou","year":"2014","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.actatropica.2015.12.017_bib0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijfoodmicro.2005.10.002","article-title":"Inhibition of phytopathogenic fungi by essential oil, hydrosol, ground material and extract of summer savory (Satureja hortensis L.) growing wild in Turkey","volume":"107","author":"Boyraz","year":"2006","journal-title":"Int. J. Food Microbiol."},{"issue":"3","key":"10.1016\/j.actatropica.2015.12.017_bib0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0001-706X(98)00061-8","article-title":"Trypanosoma cruzi genotypes associated with domestic Triatoma sordida in Bolivia","volume":"71","author":"Breni\u00e8re","year":"1998","journal-title":"Acta Trop."},{"issue":"14","key":"10.1016\/j.actatropica.2015.12.017_bib0155","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/ange.200705435","article-title":"A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors","volume":"120","author":"Buchini","year":"2008","journal-title":"Angew. Chem."},{"issue":"12","key":"10.1016\/j.actatropica.2015.12.017_bib0160","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.42.12.3245","article-title":"Induction of resistance to azole drugs in Trypanosoma cruzi","volume":"42","author":"Buckner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0165","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1128\/AAC.06244-11","article-title":"Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib","volume":"56","author":"Buckner","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0170","first-page":"89","article-title":"Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection","volume":"vol. 75","author":"Buckner","year":"2011"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0175","doi-asserted-by":"crossref","unstructured":"Buschiazzo A, Amaya MaF, Cremona MaL, Frasch AC, Alzari PM. The Crystal Structure and Mode of Action of trans-Sialidase, a Key Enzyme in Trypanosoma cruzi Pathogenesis. Molecular Cell. 2002; 10(4): 757\u2013768.","DOI":"10.1016\/S1097-2765(02)00680-9"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0180","doi-asserted-by":"crossref","first-page":"e1002474","DOI":"10.1371\/journal.ppat.1002474","article-title":"Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure\/function studies towards the rational design of inhibitors","volume":"8","author":"Buschiazzo","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0185","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/infdis\/jit420","article-title":"New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice","volume":"209","author":"Bustamante","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"March\u2013April (2)","key":"10.1016\/j.actatropica.2015.12.017_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/S0036-46652002000200008","article-title":"Oral transmission of Chagas disease: importance of Trypanosoma cruzi biodeme in the intragastric experimental infection","volume":"44","author":"Camandaroba","year":"2002","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0195","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1590\/S0037-86822003000200002","article-title":"Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain","volume":"36","author":"Camandaroba","year":"2003","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0166-6851(92)90219-A","article-title":"The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes","volume":"50","author":"Campetella","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0205","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s00436-013-3398-z","article-title":"P-glycoprotein efflux pump plays an important role in Trypanosoma cruzi drug resistance","volume":"112","author":"Campos","year":"2013","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbiopara.2014.01.002","article-title":"Benznidazole-resistance in Trypanosoma cruzi: evidence that distinct mechanisms can act in concert","volume":"193","author":"Campos","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0215","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S0036-46652006000500009","article-title":"Survival of Trypanosoma cruzi in sugar cane used to prepare juice","volume":"48","author":"Cardoso","year":"2006","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"8","key":"10.1016\/j.actatropica.2015.12.017_bib0220","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.meegid.2010.07.017","article-title":"Inheritance of resistance to pyrethroids in Triatoma infestans, the main Chagas disease vector in South America","volume":"10","author":"Cardozo","year":"2010","journal-title":"Genet. Evol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0225","article-title":"Risk factors associated with Chagas disease in pregnant women in Santander, a highly endemic Colombian area","author":"Castellanos-Dom\u00ednguez","year":"2015","journal-title":"Trop. Med. Int. Health"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0230","first-page":"19","article-title":"Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas\u2019 disease)","volume":"1","author":"Castro","year":"1988","journal-title":"BES"},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0235","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2174\/1568026023392995","article-title":"Proteinases of Trypanosoma cruzi: potential targets for the chemotherapy of Chagas disease","volume":"2","author":"Cazzulo","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijantimicag.2012.08.002","article-title":"Evaluation of benznidazole treatment combined with nifurtimox, posaconazole or AmBisome\u00ae in mice infected with Trypanosoma cruzi strains","volume":"40","author":"Cencig","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"January (1)","key":"10.1016\/j.actatropica.2015.12.017_bib0245","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2174\/1389557053402864","article-title":"Pharmacological properties of furoxans and benzofuroxans: recent developments","volume":"5","author":"Cerecetto","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1590\/S0074-02761909000200008","article-title":"Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem","volume":"1","author":"Chagas","year":"1909","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0255","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Ann. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0260","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3762\/bjoc.9.3","article-title":"Chemical\u2013biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target","volume":"9","author":"Choy","year":"2013","journal-title":"Beilst. J. Org. Chem."},{"issue":"22","key":"10.1016\/j.actatropica.2015.12.017_bib0265","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1016\/j.bmc.2003.07.004","article-title":"Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug","volume":"11","author":"Chung","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0270","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejmech.2014.11.018","article-title":"Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents","volume":"90","author":"Cogo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.actatropica.2015.12.017_bib0275","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1128\/AAC.49.4.1556-1560.2005","article-title":"Comparative efficacies of TAK-187, a Long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of chagas\u2019 disease","volume":"49","author":"Corrales","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0280","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1590\/S0074-02762007000900018","article-title":"Chagas disease: what is known and what is needed\u2014a background article","volume":"102","author":"Coura","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"May (3)","key":"10.1016\/j.actatropica.2015.12.017_bib0285","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/0074-0276140362","article-title":"The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions\u2014a comprehensive review","volume":"110","author":"Coura","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men","author":"Craig","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0295","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","article-title":"Chemotherapy of trypanosomiases and leishmaniasis","volume":"21","author":"Croft","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0300","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/683230","article-title":"Chagas disease cardiomyopathy: immunopathology and genetics","volume":"2014","author":"Cunha-Neto","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0305","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1128\/AAC.01451-09","article-title":"Hydroxymethylnitrofurazone is active in a murine model of Chagas\u2019 disease","volume":"54","author":"Davies","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0310","doi-asserted-by":"crossref","first-page":"e3231","DOI":"10.1371\/journal.pntd.0003231","article-title":"Hepatotoxicity in Mice of a Novel Anti-parasite Drug Candidate Hydroxymethylnitrofurazone: A Comparison with Benznidazole","volume":"8","author":"Davies","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0315","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.lfs.2007.04.033","article-title":"Nifurtimox nitroreductase activity in different cellular fractions from male rat pancreas. Biochemical and ultrastructural alterations","volume":"81","author":"de Mecca","year":"2007","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.actatropica.2015.12.017_bib0320","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.parint.2011.03.004","article-title":"In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham","volume":"60","author":"De Medeiros","year":"2011","journal-title":"Parasitol. Int."},{"issue":"12","key":"10.1016\/j.actatropica.2015.12.017_bib0325","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jinorgbio.2010.08.004","article-title":"Risedronate metal complexes potentially active against Chagas disease","volume":"104","author":"Demoro","year":"2010","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1590\/0037-8682-0248-2013","article-title":"The present situation, challenges, and perspectives regarding the production and utilization of effective drugs against human Chagas disease","volume":"47","author":"Dias","year":"2014","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"8","key":"10.1016\/j.actatropica.2015.12.017_bib0335","doi-asserted-by":"crossref","first-page":"e2367","DOI":"10.1371\/journal.pntd.0002367","article-title":"Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments","volume":"7","author":"Diniz Lde","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0340","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.01742-09","article-title":"Effects of ravuconazole treatment on parasite load and immune response in dogs experimentally infected with Trypanosoma cruzi","volume":"54","author":"Diniz","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.actatropica.2015.12.017_bib0345","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4269\/ajtmh.1998.59.526","article-title":"Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas\u2019 disease","volume":"59","author":"Estani","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0350","unstructured":"FDA, Federal Register. 1998."},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0355","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S0031182013000103","article-title":"Use of clomipramine as chemotherapy of the chronic phase of Chagas disease","volume":"140","author":"Fauro","year":"2013","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0360","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","article-title":"Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease","volume":"81","author":"Filardi","year":"1987","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0365","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0166-6851(98)00066-8","article-title":"Expression and cellular localization of Trypanosoma cruzi type II DNA topoisomerase","volume":"94","author":"Fragoso","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0370","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4269\/ajtmh.1990.43.159","article-title":"Therapeutic efficacy of allopurinol in patients with chronic Chagas\u2019 disease","volume":"43","author":"Gallerano","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0375","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10719-010-9300-7","article-title":"Synthesis of PEGylated lactose analogs for inhibition studies on T. cruzi trans-sialidase","volume":"27","author":"Giorgi","year":"2010","journal-title":"Glycoconj. J."},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0380","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/glycob\/cws091","article-title":"Improved bioavailability of inhibitors of Trypanosoma cruzi trans-sialidase: PEGylation of lactose analogs with multiarm polyethyleneglycol","volume":"22","author":"Giorgi","year":"2012","journal-title":"Glycobiology"},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0385","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1128\/AAC.34.9.1707","article-title":"Trypanosoma cruzi proliferation and differentiation are blocked by topoisomerase II inhibitors","volume":"34","author":"Gonzales-Perdomo","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0390","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0165-1218(89)90165-1","article-title":"Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox","volume":"224","author":"Gorla","year":"1989","journal-title":"Mutat. Res."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0395","first-page":"307","article-title":"Diminuic\u00b8ao da atividade mutagenica do pr\u00f3-f\u00e1rmaco NFOH-121 emrelac\u00b8aoaonitrofural (nitrofurazona)","volume":"22","author":"Guido","year":"2001","journal-title":"Rev. Cienc. Farm. Sao Paulo"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0400","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.actatropica.2015.12.017_bib0405","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0410","doi-asserted-by":"crossref","unstructured":"Heindel J, George J, Fail P, Grizzle T. Nitrofurazone. Environ Health Perspect. 1997; 105:331-5.","DOI":"10.2307\/3433469"},{"issue":"15","key":"10.1016\/j.actatropica.2015.12.017_bib0415","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.85.15.5374","article-title":"Subversive substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease","volume":"85","author":"Henderson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2012.10.047","article-title":"Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates","volume":"59","author":"Hern\u00e1ndez","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.canlet.2004.05.016","article-title":"Mechanism of carcinogenesis induced by a veterinary antimicrobial drug, nitrofurazone, via oxidative DNA damage and cell proliferation","volume":"215","author":"Hiraku","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0430","doi-asserted-by":"crossref","unstructured":"Inahashi Y, Iwatsuki M, Ishiyama A, Matsumoto A, Hirose T, Oshita J, et al. Actinoallolides A\u2013E, New Anti-trypanosomal Macrolides, Produced by an Endophytic Actinomycete, Actinoallomurus fulvus MK10-036. Organic Letters. 2015 2015\/02\/20; 17(4): 864-7.","DOI":"10.1021\/ol5037216"},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0435","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00775-013-1024-2","article-title":"The metal\u2013drug synergy: new ruthenium(ii) complexes of ketoconazole are highly active against leishmania major and Trypanosoma cruzi and non-toxic to human or murine normal cells","volume":"18","author":"Iniguez","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0440","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.phymed.2014.06.005","article-title":"Natural sesquiterpene lactones induce programmed cell death in Trypanosoma cruzi: a new therapeutic target?","volume":"21","author":"Jimenez","year":"2014","journal-title":"Phytomedicine"},{"issue":"15","key":"10.1016\/j.actatropica.2015.12.017_bib0445","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/cbic.200900108","article-title":"Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives","volume":"10","author":"Kim","year":"2009","journal-title":"ChemBioChem"},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0450","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20020885","article-title":"A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi","volume":"196","author":"Kubata","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-5751-13-11","article-title":"Effects of camptothecin derivatives and topoisomerase dual inhibitors on Trypanosoma cruzi growth and ultrastructure","volume":"13","author":"Lacombe","year":"2014","journal-title":"J. Negat. Results Biomed."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2015.12.017_bib0460","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijpharm.2008.09.036","article-title":"Development of novel formulations for Chagas\u2019 disease: Optimization of benznidazole chitosan microparticles based on artificial neural networks","volume":"367","author":"Leonardi","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"February","key":"10.1016\/j.actatropica.2015.12.017_bib0465","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.M510317200","article-title":"CYP51 from Trypanosoma cruzi: a phyla-specific residue in the B\u2032 helix defines substrate preferences of sterol 14\u03b1-demethylase","volume":"281","author":"Lepesheva","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0470","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2007.10.011","article-title":"Sterol 14\u03b1-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth","volume":"14","author":"Lepesheva","year":"2007","journal-title":"Chem. Biol."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0475","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/jps.22436","article-title":"The use of solid dispersion systems in hydrophilic carriers to increase benznidazole solubility","volume":"100","author":"Lima","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0480","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.ijantimicag.2003.10.006","article-title":"Thioridazine treatment prevents cardiopathy in Trypanosoma cruzi infected mice","volume":"23","author":"Lo Presti","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.actatropica.2015.02.012","article-title":"Trypanothione reductase inhibitors: overview of the action of thioridazine in different stages of Chagas disease","volume":"145","author":"Lo Presti","year":"2015","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0490","unstructured":"Lorenzi H, de Abreu Matos FJ. Plantas medicinais no Brasil: nativas e ex\u00f3ticas: Instituto Plantarum de Estudos da Flora; 2002."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0495","unstructured":"Lukes J., Trypanosomatida Kent 1880. 2009. Version 02 January 2009 (under construction). Available from: http:\/\/tolweb.org\/Trypanosomatida\/98015\/2009.01.02."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0500","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parint.2012.09.001","article-title":"Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi","volume":"62","author":"Manarin","year":"2013","journal-title":"Parasitol. Int."},{"issue":"8","key":"10.1016\/j.actatropica.2015.12.017_bib0505","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm300070h","article-title":"Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells","volume":"55","author":"Mart\u00ednez","year":"2012","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0510","first-page":"189","article-title":"histopatol\u00f3gico emcamundongos isog\u00e9nicos C3H\/HeJ eC57BL\/10 na fase aguda da infeccao com cepas de Trypanosoma cruzi isoladas nas regioes central (Goi\u00e1s) e Sul (Rio Grande do Sul) do Brasil","volume":"26","author":"Martins","year":"1998","journal-title":"Rev. Pat. Trop."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0515","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejmech.2014.05.077","article-title":"Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity","volume":"82","author":"Massarico Serafim","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0520","doi-asserted-by":"crossref","unstructured":"Maximiano FP, Hideki Yoshizane Costa Guilherme, Jacqueline dS, S\u00e9rgio SdC-FM. CARACTERIZA\u00c7\u00c3O F\u00cdSICO-QU\u00cdMICA DO F\u00c1RMACO ANTICHAG\u00c1SICO BENZNIDAZOL. Quim Nova. 2010; 33: 1714-9.","DOI":"10.1590\/S0100-40422010000800018"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0525","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/S0074-02762009000900034","article-title":"Two approaches to discovering and developing new drugs for Chagas disease","volume":"104","author":"McKerrow","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0530","doi-asserted-by":"crossref","unstructured":"Mecca MMd, Bartel LC, Castro CRd, Castro JA. Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects. Memorias do Instituto Oswaldo Cruz. 2008; 103(6): 549\u2013553.","DOI":"10.1590\/S0074-02762008000600007"},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0535","first-page":"196","article-title":"Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia","volume":"32","author":"Mej\u00eda-Jaramillo","year":"2012","journal-title":"Biom\u00e9dica"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0540","unstructured":"Melo MFF. Preparac\u00b8a\u02dco e determinac\u00b8a\u02dco da atividadetoxicol\u00f3gica do pr\u00f3-f\u00e1rmaco hidroximetilnitrofural, potencialmente antichag\u00e1sico. Araraquara, Faculdade de Cie\u02c6nciasFarmace\u02c6uticas, UNESP, Sao Paulo, Brazil, 2006."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0545","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jmgm.2013.08.009","article-title":"Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds","volume":"45","author":"Miller Iii","year":"2013","journal-title":"J. Mol. Graph. Model."},{"issue":"20","key":"10.1016\/j.actatropica.2015.12.017_bib0550","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"4703","key":"10.1016\/j.actatropica.2015.12.017_bib0555","article-title":"Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development","volume":"4","author":"Moraes","year":"2014","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0560","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1128\/AAC.05785-11","article-title":"Preclinical monitoring of drug association in experimental chemotherapy of Chagas\u2019 disease by a new HPLC\u2013UV method","volume":"56","author":"Moreira da Silva","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0565","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1073\/pnas.77.11.6810","article-title":"Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles","volume":"77","author":"Morel","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.actatropica.2015.12.017_bib0570","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0575","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1462-5822.2006.00689.x","article-title":"The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation","volume":"8","author":"Mucci","year":"2006","journal-title":"Cell. Microbiol."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0580","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-6851(98)00037-1","article-title":"Molecular characterization of susceptible and naturally resistant strains of Trypanosoma cruzi to benznidazole and nifurtimox","volume":"93","author":"Murta","year":"1998","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0585","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0166-6851(01)00350-4","article-title":"Drug resistance in Trypanosoma cruzi is not associated with amplification or overexpression of P-glycoprotein (PGP) genes","volume":"117","author":"Murta","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"issue":"January (1)","key":"10.1016\/j.actatropica.2015.12.017_bib0590","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1087057114553103","article-title":"Lead Identification to Clinical Candidate Selection: Drugs for Chagas Disease","volume":"20","author":"Neitz","year":"2015","journal-title":"J. Biomol. Screen."},{"issue":"March (7)","key":"10.1016\/j.actatropica.2015.12.017_bib0595","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/18723128112069990013","article-title":"Pharmacokinetics of hydroxymethylnitrofurazone and its parent drug nitrofurazone in rabbits","volume":"7","author":"Nogueira Filho","year":"2013","journal-title":"Drug Metab. Lett."},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0600","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1073\/pnas.95.7.3776","article-title":"Probing the genetic population structure of Trypanosoma cruzi with polymorphic microsatellites","volume":"95","author":"Oliveira","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"April (5)","key":"10.1016\/j.actatropica.2015.12.017_bib0605","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00436-008-1288-6","article-title":"Effects of essential oils from Cymbopogon citratus (DC) Stapf., Lippiasi and Ocimum gratissimum L. on growth and ultrastructure of Leishmania chagasi promastigotes","volume":"104","author":"Oliveira","year":"2009","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0610","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ejmech.2014.11.004","article-title":"Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb\/c mouse model","volume":"89","author":"Olmo","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0615","unstructured":"PAHO, 2008. Update of American Trypanosomiasis and Leishmaniasis Control and Research: Final Report."},{"issue":"4","key":"10.1016\/j.actatropica.2015.12.017_bib0620","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/1568012033483006","article-title":"Central nervous system agents used as Trypanosoma cruzi infection chemotherapy: phenothiazines and related compounds","volume":"2","author":"Paglini-Oliva","year":"2003","journal-title":"Curr. Med. Chem. Anti-Infect. Agents"},{"issue":"15","key":"10.1016\/j.actatropica.2015.12.017_bib0625","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4155\/fmc.13.108","article-title":"Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies","volume":"5","author":"Papadopoulou","year":"2013","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0630","doi-asserted-by":"crossref","DOI":"10.1021\/jm5015742","article-title":"Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents","author":"Papadopoulou","year":"2015","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0635","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/AAC.48.1.69-74.2004","article-title":"Anti-Trypanosoma cruzi activity of green tea (Camellia sinensis) catechins","volume":"48","author":"Paveto","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0640","series-title":"Medical Implications of Molecular Parasitology. Molecular Medical Parasitology","first-page":"433","author":"Pearson","year":"2003"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0645","first-page":"63","article-title":"Transmission of Chagas disease (American Trypanosomiasis) by food","volume":"vol. 59","author":"Pereira","year":"2010"},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0650","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dks390","article-title":"Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study","volume":"68","author":"Perez-Mazliah","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0655","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/AAC.01401-12","article-title":"Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease","volume":"57","author":"Pinazo","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"May (10)","key":"10.1016\/j.actatropica.2015.12.017_bib0660","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-144-10-200605160-00012","article-title":"The treatment of Chagas disease (South American trypanosomiasis) treatment of Chagas disease (South American trypanosomiasis)","volume":"144","author":"Pinto Dias","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"November\u2013December (6)","key":"10.1016\/j.actatropica.2015.12.017_bib0665","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1590\/S0037-86822008000600011","article-title":"Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Para, Amapa and Maranhao observed between 1988 and 2005","volume":"41","author":"Pinto","year":"2008","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0670","doi-asserted-by":"crossref","first-page":"e2977","DOI":"10.1371\/journal.pntd.0002977","article-title":"Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi","volume":"8","author":"Planer","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0675","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cb300648v","article-title":"Drugging topoisomerases: lessons and challenges","volume":"8","author":"Pommier","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0680","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S0074-02762009000900021","article-title":"Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification","volume":"104","author":"Rassi","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0685","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0035-9203(01)90029-X","article-title":"Effects of clomipramine on Trypanosoma cruzi infection in mice","volume":"95","author":"Rivarola","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0690","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.exppara.2005.05.005","article-title":"Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area","volume":"111","author":"Rivarola","year":"2005","journal-title":"Exp. Parasitol."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0695","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bmc.2008.11.065","article-title":"Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates","volume":"17","author":"Romeiro","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"November (5)","key":"10.1016\/j.actatropica.2015.12.017_bib0700","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4269\/ajtmh.2008.79.742","article-title":"Trypanosoma cruzi transmission cycle among wild and domestic mammals in three areas of orally transmitted Chagas disease outbreaks","volume":"79","author":"Roque","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2\u20133","key":"10.1016\/j.actatropica.2015.12.017_bib0705","first-page":"131","article-title":"The WHO\/UNDP special programme for research and training in tropical diseases","volume":"55","author":"Rowe","year":"1977","journal-title":"Bull. World Health Org."},{"issue":"10","key":"10.1016\/j.actatropica.2015.12.017_bib0710","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1462-5822.2012.01831.x","article-title":"Trypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas disease","volume":"14","author":"Rubin","year":"2012","journal-title":"Cell. Microbiol."},{"issue":"12","key":"10.1016\/j.actatropica.2015.12.017_bib0715","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1462-5822.2006.00755.x","article-title":"Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole","volume":"8","author":"Rubin-de-Celis","year":"2006","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0720","first-page":"1","article-title":"Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease","author":"S\u00e1nchez-Vald\u00e9z","year":"2014","journal-title":"Exp. Rev. Vaccines"},{"issue":"21","key":"10.1016\/j.actatropica.2015.12.017_bib0725","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2174\/092986706778201611","article-title":"Natural products from plants as drug candidates and lead compounds against leishmaniasis and trypanosomiasis","volume":"13","author":"Salem","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"14","key":"10.1016\/j.actatropica.2015.12.017_bib0730","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/jm00066a014","article-title":"Toward a novel metal-based chemotherapy against tropical diseases. 1. Enhancement of the efficacy of clotrimazole against Trypanosoma cruzi by complexation to ruthenium in RuCl2(clotrimazole) 2","volume":"36","author":"Sanchez-Delgado","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0735","doi-asserted-by":"crossref","unstructured":"Sandri, P., Aleixo, D.L., Sanchez Falkowski, G.J., Nascimento Jr., G.J., Gomes, M.L., Hernandes, L., et al., 2915. Trypanosoma cruzi: Biotherapy made from trypomastigote modulates the inflammatory response. Homeopathy 104(1); 48\u201356.","DOI":"10.1016\/j.homp.2014.05.007"},{"issue":"11","key":"10.1016\/j.actatropica.2015.12.017_bib0740","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1017\/S0031182007002958","article-title":"Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida)","volume":"134","author":"Santoro","year":"2007","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0745","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jinorgbio.2012.08.024","article-title":"Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones","volume":"117","author":"Santos","year":"2012","journal-title":"J. Inorg. Biochem."},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0750","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0169-4758(93)90017-A","article-title":"Trypanosoma cruzi trans-sialidase and cell invasion","volume":"9","author":"Schenkman","year":"1993","journal-title":"Parasitol. Today"},{"issue":"7","key":"10.1016\/j.actatropica.2015.12.017_bib0755","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0092-8674(91)90008-M","article-title":"A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells","volume":"65","author":"Schenkman","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0760","doi-asserted-by":"crossref","unstructured":"Serafim E.O.P., Silva A.T.d.A.e., Moreno A.d.H., Vizioli E.d.O., Ferreira E.I., Peccinini R.G., et al., 2013. Pharmacokinetics of Hydroxymethylnitrofurazone, a Promising New Prodrug for Chagas' Disease Treatment. Antimicrob. Agents Chemother. 57(12): 6106\u20136109. PubMed PMID: PMC3837917.","DOI":"10.1128\/AAC.02522-12"},{"issue":"September\u2013October (5)","key":"10.1016\/j.actatropica.2015.12.017_bib0765","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1590\/S0036-46651991000500003","article-title":"Possible oral transmission of acute Chagas\u2019 disease in Brazil","volume":"33","author":"Shikanai-Yasuda","year":"1991","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0770","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.175.1.169","article-title":"Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection","volume":"175","author":"Silva","year":"1992","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0775","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1128\/AAC.00070-13","article-title":"In vitro and in vivo studies of the antiparasitic activity of sterol 14\u03b1-demethylase (CYP51) inhibitor VNI against drug-resistant strains of Trypanosoma cruzi","volume":"57","author":"Soeiro","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0780","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.actatropica.2009.08.018","article-title":"Alternative lifestyles: the population structure of Trypanosoma cruzi","volume":"115","author":"Sturm","year":"2010","journal-title":"Acta Trop."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0785","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-308X(01)50032-9","article-title":"Antiparasitic properties of medicinal plants and other naturally occurring products: advances in parasitology","volume":"50","author":"Tagboto","year":"2001","journal-title":"Adv. Parasitol."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0790","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/019262330002800503","article-title":"A mechanistic study of ovarian carcinogenesis induced by nitrofurazone using rasH2 mice","volume":"28","author":"Takegawa","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0795","article-title":"Design and Preparation of pharmaceutical solid dosage forms of benznidazole for the treatment of chagas disease","author":"Tarragona Sonia","year":"2013","journal-title":"Rev. Argent. Salud P\u00fablica"},{"issue":"16","key":"10.1016\/j.actatropica.2015.12.017_bib0800","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.biortech.2006.10.019","article-title":"Screening of the antioxidative properties and total phenolic contents of three endemic Tanacetum subspecies from Turkish flora","volume":"98","author":"Tepe","year":"2007","journal-title":"Bioresour. Technol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0805","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S0074-02761988000500005","article-title":"Trypanosoma cruzi: major clones rather than principal zymodemes","volume":"83","author":"Tibayrenc","year":"1988","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0810","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1073\/pnas.83.1.115","article-title":"Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure","volume":"83","author":"Tibayrenc","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.actatropica.2015.12.017_bib0815","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1073\/pnas.90.4.1335","article-title":"Genetic characterization of six parasitic protozoa: parity between random-primer DNA typing and multilocus enzyme electrophoresis","volume":"90","author":"Tibayrenc","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0820","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-9292-2-12","article-title":"Genetic subdivisions within Trypanosoma cruzi (Discrete Typing Units) and their relevance for molecular epidemiology and experimental evolution","volume":"2","author":"Tibayrenc","year":"2003","journal-title":"Kinet. Biol. Dis."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0825","doi-asserted-by":"crossref","unstructured":"Toledo MJdO, Bahia MT, Carneiro CM, Martins-Filho OA, Tibayrenc M, Barnab\u00e9 C, et al. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrobial Agents and Chemotherapy. 2003; 47(1): 223\u201330.","DOI":"10.1128\/AAC.47.1.223-230.2003"},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0830","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/jac\/dkh224","article-title":"Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes","volume":"53","author":"Toledo","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0835","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/IAI.35.2.546-551.1982","article-title":"Genetics of murine resistance to Trypanosoma cruzi","volume":"35","author":"Trischmann","year":"1982","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0840","doi-asserted-by":"crossref","first-page":"e2844","DOI":"10.1371\/journal.pntd.0002844","article-title":"Benznidazole biotransformation and multiple targets in Trypanosoma cruzi revealed by metabolomics","volume":"8","author":"Trochine","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0845","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/14756360902941058","article-title":"Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi","volume":"25","author":"Trossini","year":"2010","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0850","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","article-title":"In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease","volume":"21","author":"Urbina","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0855","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jeu.12184","article-title":"Recent clinical trials for the etiological treatment of chronic Chagas disease: advances, challenges and perspectives","volume":"62","author":"Urbina","year":"2015","journal-title":"J. Eukaryotic Microbiol."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0860","first-page":"121","article-title":"Vaccine development against Trypanosoma cruzi and Chagas disease","volume":"vol. 75","author":"V\u00e1zquez-Chagoy\u00e1n","year":"2011"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0865","first-page":"1","article-title":"Monitoreo de resistencia a insecticidas en poblaciones de campo de Triatoma infestans y Rhodnius prolixus, insectos vectores de la Enfermedad de Chagas","volume":"3","author":"Vassena","year":"2003","journal-title":"Rev. Toxicol. L\u00ednea"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0870","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.03972-14","article-title":"SQ109: a new drug lead for chagas disease","author":"Veiga-Santos","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0875","doi-asserted-by":"crossref","unstructured":"Villela E, Villela E. Von. Trypanosoma Cruzi befallene Bestandteile des Zentralnervensystems. Z f d g Neur u Psych. 1933 1933\/12\/01; 144(1): 155\u201360. German.","DOI":"10.1007\/BF02870277"},{"issue":"1","key":"10.1016\/j.actatropica.2015.12.017_bib0880","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0002-8703(94)90521-5","article-title":"Treatment of chronic Chagas\u2019 disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up","volume":"127","author":"Viotti","year":"1994","journal-title":"Am. Heart J."},{"issue":"9","key":"10.1016\/j.actatropica.2015.12.017_bib0885","doi-asserted-by":"crossref","first-page":"e1314","DOI":"10.1371\/journal.pntd.0001314","article-title":"Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease","volume":"5","author":"Viotti","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0890","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/AAC.01662-13","article-title":"Towards a paradigm shift in the treatment of chronic chagas disease","volume":"58","author":"Viotti","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0895","series-title":"Control of Chagas Disease: Second Report of the WHO Expert Committee","author":"WHO","year":"2002"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0900","series-title":"Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases: Second Who Report on Neglected Diseases","author":"WHO","year":"2013"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0905","doi-asserted-by":"crossref","unstructured":"Wang X, Sun H. Metal Complexes in the Treatment of Tropical Diseases: Malaria, Trypanosomiasis, and Leishmaniasis. Comprehensive inorganic chemistry II: from elements to applications (2nd ed). 2013;3:975-86.","DOI":"10.1016\/B978-0-08-097774-4.00339-9"},{"issue":"25","key":"10.1016\/j.actatropica.2015.12.017_bib0910","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1021\/ja0344967","article-title":"Trypanosoma cruzi trans-sialidase operates through a covalent sialyl\u2014enzyme intermediate: tyrosine is the catalytic nucleophile","volume":"125","author":"Watts","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.actatropica.2015.12.017_bib0915","unstructured":"Weiss Louis M., Tanowitz Herbert B., V. KL. Advances in parasitology Ltd E, editor, 2011."},{"issue":"13","key":"10.1016\/j.actatropica.2015.12.017_bib0920","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.actatropica.2015.12.017_bib0925","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.2174\/156802611796575894","article-title":"Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives","volume":"11","author":"Wilkinson","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"1590","key":"10.1016\/j.actatropica.2015.12.017_bib0930","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1098\/rstb.2011.0296","article-title":"Host genetics and population structure effects on parasitic disease","volume":"367","author":"Williams-Blangero","year":"2012","journal-title":"Philos. Trans. R. Soc. B"},{"issue":"2260","key":"10.1016\/j.actatropica.2015.12.017_bib0935","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1126\/science.87.2260.366","article-title":"A new locality for Trypanosoma cruzi Chagas in California","volume":"87","author":"Wood","year":"1938","journal-title":"Science"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.actatropica.2015.12.017_bib0940","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S0074-02762009000900015","article-title":"Molecular mechanisms of Trypanosoma cruzi infection by oral route","volume":"104","author":"Yoshida","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2015.12.017_bib0945","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","article-title":"A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI","volume":"104","author":"Zingales","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.actatropica.2015.12.017_bib0950","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1590\/0074-0276140156","article-title":"Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity","volume":"109","author":"Zingales","year":"2014","journal-title":"Mem. Inst. Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.actatropica.2015.12.017_bib0955","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.molbiopara.2014.02.001","article-title":"How Trypanosoma cruzi handles cell cycle arrest promoted by camptothecin, a topoisomerase I inhibitor","volume":"193","author":"Zuma","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/j.actatropica.2015.12.017_bib0960","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijantimicag.2010.11.031","article-title":"Effect of topoisomerase inhibitors and DNA-binding drugs on the cell proliferation and ultrastructure of Trypanosoma cruzi","volume":"37","author":"Zuma","year":"2015","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15301947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X15301947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T11:07:17Z","timestamp":1599995237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X15301947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":192,"alternative-id":["S0001706X15301947"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.12.017","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current drug therapy and pharmaceutical challenges for Chagas disease","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2015.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}